Are There Any Clinical Trials Involving Nicotinic Receptor Antagonists?
Yes, there are ongoing clinical trials investigating the efficacy of nicotinic receptor antagonists in various types of cancer. These trials aim to evaluate the safety and effectiveness of these drugs in combination with other cancer treatments. Preliminary results have been promising, showing reduced tumor growth and increased survival rates in some cases.
